Circulating CD14+CD16− classical monocytes do not associate with a vulnerable plaque phenotype, and do not predict secondary events in severe atherosclerotic patients

2019/01/07 by John A.L. Meeuwsen, Judith J. de Vries, Amerik van Duijvenvoorde +10 · 9 citations
Immunology and Microbiology · Medicine · #Immune cells in cancer #Chemokine receptors and signaling #Inflammatory Biomarkers in Disease Prognosis

paper · pdf · doi:10.1016/j.yjmcc.2019.01.002

Cited by

• The Role of Monocytes and Macrophages in Human Atherosclerosis, Plaque Neoangiogenesis, and Atherothrombosis. [europepmc]
• Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases. [europepmc]
• Relationship between Circulating Inflammatory Monocytes and Cardiovascular Disease Measures of Carotid Intimal Thickness. [europepmc]
• The March of Monocytes in Atherosclerosis: One Cell at a Time. [europepmc]
• Trafficking of Mononuclear Phagocytes in Healthy Arteries and Atherosclerosis. [europepmc]
• Immune system and atherosclerosis: Hostile or friendly relationship. [europepmc]
• Increased frequency of proangiogenic tunica intima endothelial kinase 2 (Tie2) expressing monocytes in individuals with type 2 diabetes mellitus. [europepmc]
• Coronary atherosclerosis severity is closely associated with decreased GLP-1R positivity among CD16 + pro-inflammatory and patrolling monocyte subsets. [europepmc]
• Molecular and cellular mechanisms of inflammation in atherosclerosis. [europepmc]